Lakewood-Amedex Biotherapeutics, Inc. (LABT)

Price & Market Data

Price: $0.69

Daily Change: -$0.0165 / 2.39%

Daily Range: $0.622 - $0.74

Market Cap: $10,196,101

Daily Volume: 431,235

Performance Metrics

1 Week: -47.66%

1 Month: -91.83%

3 Months: -91.17%

6 Months: -91.17%

1 Year: -91.17%

YTD: -91.17%

About Lakewood-Amedex Biotherapeutics, Inc. (LABT)

Key metrics for Lakewood-Amedex Biotherapeutics, Inc. (LABT). Current price: 0.69, daily change: -$0.0165 / 2.39%. Market cap: 10,196,101. Performance across all periods for quick analysis.

Company Details

Employees: 5

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents that fight infections by disrupting microbial membranes. It also develops Nu-3, a topical antimicrobial for infected diabetic foot ulcers. The company was formerly known as Lakewood-Amedex Inc. and changed its name to Lakewood-Amedex Biotherapeutics, Inc. in June 2025. Lakewood-Amedex Biotherapeutics, Inc. was incorporated in 2006 and is headquartered in University Park, Florida.

Selected stocks

Polaryx Therapeutics, Inc. (PLYX)

Air Global PLC (AIIR)

Nicola Mining Inc. (NICM)

Russell 2000 ETF (IWM)

EquipmentShare.com Inc (EQPT)